Current Report Filing (8-k)
September 23 2016 - 3:57PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 21, 2016
OptimizeRx Corporation
(Exact name of registrant as specified in its charter)
Nevada
|
|
000-53605
|
|
26-1265381
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
400
Water Street, Suite 200, Rochester, MI
|
|
48307
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
248.651.6568
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
SECTION
8 – Other Events
On
September 21, 2016, our Board of Directors adopted a charter for our newly created Nominating and Governance Committee (the “Committee”).
The Committee is responsible for the oversight of our director nominations process, including recommending nominees to the Board
of Directors for approval and for the development and maintenance of our corporate governance policies.
Our
Board of Directors appointed the following persons to the Committee: Lynn Vos, Gus Halas and Jack Pinney, with Mr. Halas serving
as Chairperson.
A
copy of the Nominating and Governance Committee Charter is attached hereto as Exhibit 99.1 and will be posted on our corporate
website at
www.optimizerxcorp.com
.
SECTION
9 – Financial Statements and Exhibits
Item 9.01
|
Financial Statements and Exhibits
|
Exhibit
No.
|
|
Description
|
99.1
|
|
Nominating
and Governance Committee Charter
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
OptimizeRx Corporation
|
|
|
Date: September 23, 2016
|
/s/ Doug
Baker
|
|
Doug Baker
|
|
Chief Financial Officer
|
|
|
|
|
3
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Apr 2024 to May 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From May 2023 to May 2024